SMAD1 and prostate carcinoma: Consistent with this conclusion, we showed previously that the introduction of PAWS1 in PC3 prostate cancer cells (that normally do not express PAWS1) does not affect BMP‐induced phosphorylation of SMAD1, nor the transcription of SMAD4‐dependent BMP target genes 1.